ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

Why Lymphoma, Mantle-Cell is on this study

  • ClinicalTrials.gov files the study under Lymphoma, Mantle-Cell.
  • It is the study's main condition, by the main-condition rule: the study is compared with others under Lymphoma, Mantle-Cell.
9 links0 made here, not in the record11 judgments1 judge (the rules as one: Rule based)1 record change seen
Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT02427620Ibrutinib, Rituximab, andConsolidation Chemotherapyin Treating Young PatientsWith Newly Diagnosed MantleCell LymphomaM.D. Anderson Cancer CenterPhase 2 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 10 · ClinicalTrials.gov record · Version of 2026-11-10Version of 2026-11-10CONDITIONSLymphoma, Mantle-CellThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSCyclophosphamideIntervention entry›As of now · Rule based · BackgroundBackgroundCytarabineIntervention entry›As of now · Rule based · BackgroundBackgroundDexamethasoneIntervention entry›As of now · Rule based · BackgroundBackgroundDoxorubicinIntervention entry›As of now · Rule based · BackgroundAs of now · Rule based · BackgroundBackgroundIbrutinibIntervention entry›As of now · Rule based · TestedTestedMethotrexateIntervention entry›As of now · Rule based · BackgroundBackgroundRituximabIntervention entry›As of now · Rule based · TestedTestedVincristineIntervention entry›As of now · Rule based · BackgroundAs of now · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
1 version of the record seen on ClinicalTrials.gov, Nov 10 · changes seen, not judgments
As of nowLymphoma, Mantle-CellRule based · main-condition ruleMain conditionCurrent
As of nowCyclophosphamideRule based · role ruleBackgroundCurrent
As of nowCytarabineRule based · role ruleBackgroundCurrent
As of nowDexamethasoneRule based · role ruleBackgroundCurrent
As of nowDoxorubicinRule based · role ruleBackgroundCurrent
As of nowDoxorubicinRule based · role ruleBackgroundCurrent
As of nowIbrutinibRule based · role ruleTestedCurrent
As of nowMethotrexateRule based · role ruleBackgroundCurrent
As of nowRituximabRule based · role ruleTestedCurrent
As of nowVincristineRule based · role ruleBackgroundCurrent
As of nowVincristineRule based · role ruleBackgroundCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.